Phase I Study of Chemotherapy and Irreversible Electroporation (IRE) in the Treatment of Advanced Pancreatic Adenocarcinoma
Summary
The purpose of this phase I study is to compare the efficacy and tolerability of IRE in combination with either FOLFIRINOX or gemcitabine in patients with locally advanced pancreatic cancer.
General Information
NCT#: NCT03484299
Study ID: 17.0529
Trial Phase: Phase I
Trial Sponsor: University of Louisville
Therapies Used in This Trial: Fluorouracil, Gemcitabine, Oxaliplatin, Irinotecan, Leucovorin, Irreversible Electroporation (IRE), FOLFIRINOX